May 2, 2018

Athersys Announces Funding for Clinical Trial in Houston

Athersys, in partnership with the University of Texas Health Center at Houston, receives $3.5 million total in grants from the Medical Technology Enterprise Consortium and the Memorial Hermann Foundation to conduct a Phase 2 clinical trial evaluating its MultiStem cell therapy for early treatment and prevention of complications after severe traumatic injury.